ClinConnect ClinConnect Logo
Search / Trial NCT05689112

Microscopy Imaging of Whole-mount Stained Human Tissues

Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jan 9, 2023

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Intraoperative Assessment Whole Mount H&E Staining Surgical Border Assessment

ClinConnect Summary

This clinical trial is studying a new way to quickly examine tumor tissue during surgery. The goal is to develop a special imaging method that allows doctors to see the edges of tumors right away, without the lengthy processes usually required in traditional testing. This could help ensure that all of the tumor is removed during surgery, which is important for successful treatment. The trial will involve 250 patients who are having surgery to remove tumors from the brain, breast, or skin. Participants will provide a small piece of their tumor tissue for this study.

To join the trial, patients must be over 20 years old and diagnosed with a tumor in the skin, brain, or breast. However, those who have difficulty communicating or whose tumors are very small (under 1 centimeter) cannot participate. If you decide to take part, you can expect to contribute a small sample of your tumor tissue, which researchers will use to compare with normal tissue to see how effective the new imaging method is. The trial is currently looking for participants, and this research could lead to improvements in how surgeons detect and treat tumors in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients who are more than 20 years old.
  • 2. Diagnosed as patients suffered by skin tumor, brain tumor and breast tumor.
  • Exclusion Criteria:
  • 1. Patients who can't speak and communicate with others.
  • 2. Patients who can't make eventual and exact pathological assessment for his/her diseases.
  • 3. Patients who only can fit for slicing tumor.
  • 4. Removed tissues which obviously vary after severe ray radiation under microscopy observation.
  • 5. Diameter of tumors are under 1 centimeter.
  • 6. Breast carcinoma in situ.

About National Taiwan University Hospital

National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials